Genflow Biosciences plc (LON:GENF – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 2.70 and last traded at GBX 2.67, with a volume of 2744522 shares. The stock had previously closed at GBX 2.50.
Genflow Biosciences Trading Up 6.7%
The stock has a market capitalization of £14.29 million, a price-to-earnings ratio of -5.31 and a beta of 2.24. The firm has a 50-day moving average of GBX 1.95 and a 200 day moving average of GBX 1.93.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Stories
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
